TickerFactsScreenerDevelopers

VYNE Therapeutics Inc. (VYNE) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2016: $12.49M2017: $14.57M2018: $9.55M2019: $63.58M2020: $56.25M2021: $18.41M2022: $9.35M2023: $8.95M2024: $14.82M2025: $2.40M$2.40M
2016Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$2.40M-83.8%
2024$14.82M+65.6%
2023$8.95M-4.2%
2022$9.35M-49.2%
2021$18.41M-67.3%
2020$56.25M-11.5%
2019$63.58M+565.7%
2018$9.55M-34.5%
2017$14.57M+16.7%
2016$12.49M—